NIH-funded research R21 grant

Investigating muscle cells to improve diagnosis of chronic fatigue syndrome

Official title: Transcriptional profiling of proliferative skeletal muscle mononucleated cells coupled with broadband electrical cytometry towards diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome

Funded at Lehigh University · NIH-10951972 · Data updated 2026-11-12

This study is looking at muscle cells from people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) to find out how they differ from those of healthy individuals, with the hope of discovering new ways to diagnose and better understand the condition, especially for those who developed symptoms after COVID-19.

More Fatigue research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionLehigh University
NIH-funded
Lab location1 site (Bethlehem, United States)
Project startSeptember 4, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$390,178
NIH project number1R21NS139044-01
Project IDNIH-10951972 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 21 and older who have been diagnosed with myalgic encephalomyelitis/chronic fatigue syndrome.

Less likely to help

Patients who do not have ME/CFS or related chronic fatigue conditions may not benefit from this research.

What this research studies

This research focuses on understanding myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) by analyzing muscle cells from patients. Researchers will use advanced techniques to profile the gene expression and electrical properties of these cells, comparing them to those from healthy individuals. The goal is to identify specific biological markers that can lead to better diagnostic tools for ME/CFS, especially in patients who may have developed symptoms following COVID-19. By examining these cellular characteristics, the study aims to enhance the understanding of the disease and improve patient care.

Why it matters

Potential benefit: If successful, this research could lead to the development of reliable diagnostic tests for ME/CFS, improving patient outcomes and treatment options.

How similar studies have gone: While there has been limited research specifically using this approach, the investigation of cellular markers in chronic fatigue conditions is a growing area of interest, suggesting potential for success.

Where this research is happening

  • Lehigh University
    Bethlehem, United States
    Active

Researchers

  • Principal investigator: Cheng, Xuanhong — Lehigh University
  • Study coordinator: Cheng, Xuanhong

Related research

Other NIH-funded projects on the same topics.

  • Human Herpesvirus 6B and ME/CFS: does the virus cause or follow immune problems?

    A study to see if HHV-6B reactivation is a cause or result of immune problems in people with ME/CFS, using long-term follow-up and biosamples from patients and controls.

    NIH research London Sch/hygiene & Tropical Medicine · London, United Kingdom · NIH-11403869

  • Long COVID as a possible subtype of chronic fatigue syndrome

    A study at a major hospital will look at whether Long COVID shares biology with chronic fatigue syndrome and what genetic and immune factors may link them.

    NIH research Massachusetts General Hospital · Boston, United States · NIH-11391125

  • Is Long COVID a subtype of chronic fatigue syndrome?

    This project looks at whether people with Long COVID share the same genetic and immune signs as people with chronic fatigue syndrome by analyzing large collections of patient data.

    NIH research Massachusetts General Hospital · Boston, United States · NIH-11381943

  • HHV-6B (a common herpesvirus) and its link to ME/CFS and Long COVID

    This project will follow adults with ME/CFS, some with Long COVID, and healthy controls over time to find out whether reactivation of herpesvirus HHV-6B is linked to changes in symptoms and immune responses.

    NIH research London Sch/hygiene & Tropical Medicine · London, United Kingdom · NIH-11159442

  • Long COVID may be a form of chronic fatigue syndrome

    This project looks for shared genetic and immune causes in people with Long COVID and people with chronic fatigue syndrome to explain lingering symptoms.

    NIH research Massachusetts General Hospital · Boston, United States · NIH-11143218

  • Investigating T Cell Responses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

    This study is looking at how a type of immune cell called T cells behaves in people with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) compared to healthy individuals, to help uncover clues about the condition and find better ways to treat it.

    NIH research Univ of Massachusetts Med Sch Worcester · Worcester, United States · NIH-11044125

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.